Safety profile of maraviroc in patients coinfected with HIV-1 and hepatitis B or C included in the maraviroc expanded access program.
about
The maraviroc expanded access program - safety and efficacy data from an open-label study.Effects of the Chemokine Receptor 5 (CCR5)-Delta32 Mutation on Hepatitis C Virus-Specific Immune Responses and Liver Tissue Pathology in HCV Infected Patients.Clinical significance of the CCR5delta32 allele in hepatitis CLiver Toxicity of Current Antiretroviral Regimens in HIV-Infected Patients with Chronic Viral Hepatitis in a Real-Life Setting: The HEPAVIR SEG-HEP Cohort.Treatment of genotype 2 and genotype 3 hepatitis C virus (HCV) infection in human immunodeficiency virus positive patients.Treatment of chronic hepatitis C in patients with HIV/HCV coinfectionPreclinical discovery and development of maraviroc for the treatment of HIV.Liver toxicity and risk of discontinuation in HIV/hepatitis C virus-coinfected patients receiving an etravirine-containing antiretroviral regimen: influence of liver fibrosis.
P2860
Q30911112-692613D4-3796-48E2-B9CD-942D4D4F1337Q33912466-79CD8F65-5EA5-4201-9E40-A44428E25FAEQ34142349-A196DCAF-2704-4C75-BA6D-CA0A21B87476Q35915593-B050BE31-69F1-4670-9392-D09BCB533F70Q38164262-233D466B-B244-4398-8017-5855FAC68CAFQ38352572-9A4F4CFA-E4CD-4B2D-B6E1-7B3BEEEABEC1Q39556338-0A35FAFD-29CF-4B83-BCB9-1DF3F40204EAQ40784890-96C9B0B7-AC6C-4C8C-9956-8824AD68F3E7
P2860
Safety profile of maraviroc in patients coinfected with HIV-1 and hepatitis B or C included in the maraviroc expanded access program.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Safety profile of maraviroc in ...... viroc expanded access program.
@en
Safety profile of maraviroc in ...... viroc expanded access program.
@nl
type
label
Safety profile of maraviroc in ...... viroc expanded access program.
@en
Safety profile of maraviroc in ...... viroc expanded access program.
@nl
prefLabel
Safety profile of maraviroc in ...... viroc expanded access program.
@en
Safety profile of maraviroc in ...... viroc expanded access program.
@nl
P2093
P2860
P356
P1433
P1476
Safety profile of maraviroc in ...... viroc expanded access program.
@en
P2093
Geoffrey Mukwaya
Jayvant Heera
Srinivas R Valluri
P2860
P356
10.1310/HCT1302-83
P577
2012-03-01T00:00:00Z